Literature DB >> 9696804

Phosphorylation of structural components promotes dissociation of the herpes simplex virus type 1 tegument.

E E Morrison1, Y F Wang, D M Meredith.   

Abstract

The role of phosphorylation in the dissociation of structural components of the herpes simplex virus type 1 (HSV-1) tegument was investigated, using an in vitro assay. Addition of physiological concentrations of ATP and magnesium to wild-type virions in the presence of detergent promoted the release of VP13/14 and VP22. VP1/2 and the UL13 protein kinase were not significantly solubilized. However, using a virus with an inactivated UL13 protein, we found that the release of VP22 was severely impaired. Addition of casein kinase II (CKII) to UL13 mutant virions promoted VP22 release. Heat inactivation of virions or addition of phosphatase inhibited the release of both proteins. Incorporation of radiolabeled ATP into the assay demonstrated the phosphorylation of VP1/2, VP13/14, VP16, and VP22. Incubation of detergent-purified, heat-inactivated capsid-tegument with recombinant kinases showed VP1/2 phosphorylation by CKII, VP13/14 phosphorylation by CKII, protein kinase A (PKA), and PKC, VP16 phosphorylation by PKA, and VP22 phosphorylation by CKII and PKC. Proteolytic mapping and phosphoamino acid analysis of phosphorylated VP22 correlated with previously published work. The phosphorylation of virion-associated VP13/14, VP16, and VP22 was demonstrated in cells infected in the presence of cycloheximide. Use of equine herpesvirus 1 in the in vitro release assay resulted in the enhanced release of VP10, the homolog of HSV-1 VP13/14. These results suggest that the dissociation of major tegument proteins from alphaherpesvirus virions in infected cells may be initiated by phosphorylation events mediated by both virion-associated and cellular kinases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9696804      PMCID: PMC109932          DOI: 10.1128/JVI.72.9.7108-7114.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Suppression of the synthesis of cellular macromolecules by herpes simplex virus.

Authors:  M L Fenwick; M J Walker
Journal:  J Gen Virol       Date:  1978-10       Impact factor: 3.891

2.  Antigenic and protein sequence homology between VP13/14, a herpes simplex virus type 1 tegument protein, and gp10, a glycoprotein of equine herpesvirus 1 and 4.

Authors:  G R Whittaker; M P Riggio; I W Halliburton; R A Killington; G P Allen; D M Meredith
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

3.  A single serine residue at position 375 of VP16 is critical for complex assembly with Oct-1 and HCF and is a target of phosphorylation by casein kinase II.

Authors:  D O'Reilly; O Hanscombe; P O'Hare
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

4.  Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpesvirion.

Authors:  P G Spear; B Roizman
Journal:  J Virol       Date:  1972-01       Impact factor: 5.103

5.  Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcription.

Authors:  M E Campbell; J W Palfreyman; C M Preston
Journal:  J Mol Biol       Date:  1984-11-25       Impact factor: 5.469

6.  Molecular genetics of herpes simplex virus. VIII. further characterization of a temperature-sensitive mutant defective in release of viral DNA and in other stages of the viral reproductive cycle.

Authors:  W Batterson; D Furlong; B Roizman
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

7.  Identification and characterization of the virion protein products of herpes simplex virus type 1 gene UL47.

Authors:  G McLean; F Rixon; N Langeland; L Haarr; H Marsden
Journal:  J Gen Virol       Date:  1990-12       Impact factor: 3.891

8.  Identification and characterization of a novel non-infectious herpes simplex virus-related particle.

Authors:  J F Szilágyi; C Cunningham
Journal:  J Gen Virol       Date:  1991-03       Impact factor: 3.891

9.  Herpes simplex virus phosphoproteins. II. Characterization of the virion protein kinase and of the polypeptides phosphorylated in the virion.

Authors:  S Lemaster; B Roizman
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

10.  Proteins specified by herpes simplex virus. XII. The virion polypeptides of type 1 strains.

Authors:  J W Heine; R W Honess; E Cassai; B Roizman
Journal:  J Virol       Date:  1974-09       Impact factor: 5.103

View more
  73 in total

1.  Identification of phosphorylation sites within the herpes simplex virus tegument protein VP22.

Authors:  G Elliott; D O'Reilly; P O'Hare
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Nuclear localization and shuttling of herpes simplex virus tegument protein VP13/14.

Authors:  M Donnelly; G Elliott
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  Cytomegalovirus basic phosphoprotein (pUL32) binds to capsids in vitro through its amino one-third.

Authors:  M K Baxter; W Gibson
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Assembly of infectious Herpes simplex virus type 1 virions in the absence of full-length VP22.

Authors:  L E Pomeranz; J A Blaho
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 5.  Viral serine/threonine protein kinases.

Authors:  Thary Jacob; Céline Van den Broeke; Herman W Favoreel
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

6.  Distinctions between bovine herpesvirus 1 and herpes simplex virus type 1 VP22 tegument protein subcellular associations.

Authors:  J S Harms; X Ren; S C Oliveira; G A Splitter
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

7.  Role of the VP16-binding domain of vhs in viral growth, host shutoff activity, and pathogenesis.

Authors:  Stephanie S Strand; David A Leib
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

8.  Entry of pseudorabies virus: an immunogold-labeling study.

Authors:  Harald Granzow; Barbara G Klupp; Thomas C Mettenleiter
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

9.  Characterization of VP22 in herpes simplex virus-infected cells.

Authors:  G Mouzakitis; John McLauchlan; Cristina Barreca; Lisa Kueltzo; P O'Hare
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

10.  Temporal regulation of herpes simplex virus type 2 VP22 expression and phosphorylation.

Authors:  B J Geiss; J E Tavis; L M Metzger; D A Leib; L A Morrison
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.